T. Rowe Price Associates’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396M | Buy |
1,871,712
+5,425
| +0.3% | +$1.17M | 0.05% | 296 |
|
|
2025
Q4 | $384M | Sell |
1,866,287
-101,410
| -5% | -$19.1M | 0.04% | 307 |
|
|
2025
Q3 | $309M | Buy |
1,967,697
+336,777
| +21% | +$52M | 0.03% | 349 |
|
|
2025
Q2 | $274M | Sell |
1,630,920
-23,116
| -1% | -$3.43M | 0.03% | 373 |
|
|
2025
Q1 | $228M | Buy |
1,654,036
+52,714
| +3% | +$6.72M | 0.03% | 396 |
|
|
2024
Q4 | $189M | Buy |
1,601,322
+55,781
| +4% | +$6.51M | 0.02% | 443 |
|
|
2024
Q3 | $171M | Sell |
1,545,541
-574,861
| -27% | -$60.1M | 0.02% | 463 |
|
|
2024
Q2 | $208M | Sell |
2,120,402
-610,452
| -22% | -$62.2M | 0.02% | 410 |
|
|
2024
Q1 | $306M | Buy |
2,730,854
+14,030
| +0.5% | +$1.51M | 0.04% | 355 |
|
|
2023
Q4 | $274M | Buy |
2,716,824
+273,125
| +11% | +$27.1M | 0.04% | 355 |
|
|
2023
Q3 | $212M | Sell |
2,443,699
-771,943
| -24% | -$69.8M | 0.03% | 382 |
|
|
2023
Q2 | $304M | Sell |
3,215,642
-1,424,671
| -31% | -$120M | 0.04% | 324 |
|
|
2023
Q1 | $350M | Sell |
4,640,313
-353,774
| -7% | -$26.7M | 0.05% | 296 |
|
|
2022
Q4 | $384M | Sell |
4,994,087
-3,207,939
| -39% | -$244M | 0.06% | 273 |
|
|
2022
Q3 | $547M | Sell |
8,202,026
-3,641,139
| -31% | -$231M | 0.09% | 206 |
|
|
2022
Q2 | $619M | Sell |
11,843,165
-3,055,818
| -21% | -$174M | 0.08% | 244 |
|
|
2022
Q1 | $845M | Sell |
14,898,983
-129,784
| -0.9% | -$6.95M | 0.09% | 234 |
|
|
2021
Q4 | $774M | Buy |
15,028,767
+605,853
| +4% | +$29.7M | 0.07% | 270 |
|
|
2021
Q3 | $713M | Buy |
14,422,914
+1,438,136
| +11% | +$78M | 0.07% | 283 |
|
|
2021
Q2 | $741M | Buy |
12,984,778
+3,338,519
| +35% | +$195M | 0.07% | 280 |
|
|
2021
Q1 | $586M | Buy |
9,646,259
+640,591
| +7% | +$35.4M | 0.06% | 304 |
|
|
2020
Q4 | $482M | Buy |
9,005,668
+322,495
| +4% | +$16.7M | 0.05% | 330 |
|
|
2020
Q3 | $408M | Buy |
8,683,173
+650,129
| +8% | +$33.4M | 0.05% | 336 |
|
|
2020
Q2 | $419M | Sell |
8,033,044
-280,058
| -3% | -$14.4M | 0.05% | 321 |
|
|
2020
Q1 | $399M | Buy |
8,313,102
+2,612,217
| +46% | +$136M | 0.06% | 292 |
|
|
2019
Q4 | $288M | Buy |
5,700,885
+992,913
| +21% | +$51.3M | 0.04% | 407 |
|
|
2019
Q3 | $222M | Buy |
4,707,972
+502,584
| +12% | +$22.9M | 0.03% | 432 |
|
|
2019
Q2 | $198M | Buy |
4,205,388
+217,385
| +5% | +$10M | 0.03% | 467 |
|
|
2019
Q1 | $192M | Buy |
3,988,003
+11,570
| +0.3% | +$580K | 0.03% | 482 |
|
|
2018
Q4 | $177M | Buy |
3,976,433
+508,784
| +15% | +$26.5M | 0.03% | 467 |
|
|
2018
Q3 | $187M | Sell |
3,467,649
-150,082
| -4% | -$7.68M | 0.03% | 502 |
|
|
2018
Q2 | $177M | Buy |
3,617,731
+1,834,446
| +103% | +$104M | 0.03% | 505 |
|
|
2018
Q1 | $112M | Sell |
1,783,285
-154,735
| -8% | -$10.6M | 0.02% | 615 |
|
|
2017
Q4 | $119M | Buy |
1,938,020
+1,040,506
| +116% | +$64.3M | 0.02% | 586 |
|
|
2017
Q3 | $60.1M | Buy |
897,514
+45,492
| +5% | +$3.22M | 0.01% | 782 |
|
|
2017
Q2 | $66.4M | Buy |
852,022
+39,779
| +5% | +$3M | 0.01% | 736 |
|
|
2017
Q1 | $66.2M | Sell |
812,243
-79,163
| -9% | -$6.23M | 0.01% | 713 |
|
|
2016
Q4 | $64.2M | Sell |
891,406
-483,718
| -35% | -$35M | 0.01% | 732 |
|
|
2016
Q3 | $107M | Sell |
1,375,124
-1,597,030
| -54% | -$129M | 0.02% | 559 |
|
|
2016
Q2 | $232M | Sell |
2,972,154
-2,343,773
| -44% | -$187M | 0.05% | 371 |
|
|
2016
Q1 | $436M | Buy |
5,315,927
+177,997
| +3% | +$14.5M | 0.09% | 244 |
|
|
2015
Q4 | $459M | Sell |
5,137,930
-95,909
| -2% | -$8.14M | 0.1% | 225 |
|
|
2015
Q3 | $402M | Buy |
5,233,839
+596,773
| +13% | +$49.9M | 0.09% | 250 |
|
|
2015
Q2 | $388M | Buy |
4,637,066
+74,777
| +2% | +$6.6M | 0.08% | 279 |
|
|
2015
Q1 | $412M | Sell |
4,562,289
-373,859
| -8% | -$32.2M | 0.09% | 268 |
|
|
2014
Q4 | $398M | Sell |
4,936,148
-5,566,378
| -53% | -$440M | 0.08% | 278 |
|
|
2014
Q3 | $787M | Sell |
10,502,526
-170,557
| -2% | -$12.4M | 0.17% | 149 |
|
|
2014
Q2 | $732M | Buy |
10,673,083
+686,277
| +7% | +$46.7M | 0.16% | 161 |
|
|
2014
Q1 | $699M | Buy |
9,986,806
+2,371,422
| +31% | +$165M | 0.16% | 164 |
|
|
2013
Q4 | $509M | Buy |
7,615,384
+5,923,834
| +350% | +$362M | 0.12% | 210 |
|
|
2013
Q3 | $88.2M | Buy |
1,691,550
+1,086,060
| +179% | +$55.2M | 0.02% | 626 |
|
|
2013
Q2 | $28.6M | Buy |
+605,490
| New | +$27.7M | 0.01% | 972 |
|
Other funds holding CAH
VCM
VPM
T. Rowe Price Associates's CAH Position: Q1 2026 in Review
T. Rowe Price Associates increased its Cardinal Health (CAH) stake by 0.29% in Q1 2026, buying an estimated $1.17M and bringing the position to 1,871,712 shares worth $396M. The position accounts for 0.05% of the portfolio, ranked #296.
T. Rowe Price Associates first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $845M in Q1 2022. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- T. Rowe Price Associates held 1,871,712 shares of Cardinal Health worth $396M as of Q1 2026.
- T. Rowe Price Associates bought 5,425 Cardinal Health shares in Q1 2026, an estimated $1.17M.
- Cardinal Health made up 0.05% of T. Rowe Price Associates's portfolio in Q1 2026, its #296 holding.
- T. Rowe Price Associates first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Cardinal Health position peaked at $845M in Q1 2022.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.